Skip to content

Exploring the Impact of Various Dietary Patterns on Blood Glucose Control in Diabetics Using Dynamic Monitoring and Deep Learning

Exploring the Impact of Various Dietary Patterns on Blood Glucose Control in Diabetics Using Dynamic Monitoring and Deep Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111532
Enrollment
Unknown
Registered
2025-11-01
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Moderate-Carbohydrate/High Omega-3 Group:Moderate-carbohydrate diet (CHO:PRO:FAT = 40%:30%:30%), 6 fish oil capsules per day.
Moderate-Carbohydrate/Low Omega-3 Group:Moderate-carbohydrate diet (CHO:PRO:FAT = 40%:30%:30%), 6 corn oil capsules per day.
High-Carbohydrate/Low Omega-3 Group:High-carbohydrate diet (CHO:PRO:FAT = 55%:15%:30%), 6 corn oil capsules per day.

Sponsors

Longgang Central Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Patients newly diagnosed with type 2 diabetes within 3 months; 2. Glycated hemoglobin is between 6.5% and 7.5%. 3. Age between 18 and 60 years old; 4.BMI (kg/m^2) is between 18.5 and 23.9. 5. Systolic blood pressure: 90-120mmHg, diastolic blood pressure: 60-90 MMHG. 6. Good compliance, able to cooperate with research investigations, adhere to standardized nutrition management and sign informed consent forms; 7. The medication situation remained basically stable during the intervention period. 8. No n-3 PUFA-related products have been used.

Exclusion criteria

Exclusion criteria: 1.Subjects who were unwilling to continue participating in this study; 2. Subjectively unable to adhere to the intervention plan, or monitoring subjects who did not implement the intervention plan through biomarkers; 3. Subjects who experienced adverse reactions..

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;Postprandial blood glucose;

Secondary

MeasureTime frame
Glycated hemoglobin;Insulin;C-peptide;Total cholesterol;Total triglycerides;Low-Density Lipoprotein Cholesterol (LDL-C);High-Density Lipoprotein Cholesterol (HDL-C);Creatinine;Urea;Estimated glomerular filtration rate;Uric acid;Alanine Aminotransferase (ALT);Aspartate Aminotransferase (AST);Albumin;Prealbumin;Interleukin-6 (IL-6);Tumor Necrosis Factor-alpha (TNF-a);C-reactive protein (CRP);Procalcitonin (PCT);Body composition analysis;Fatty acids profile and metabolites (n-3, n-6 PUFA, etc.);

Countries

China

Contacts

Public ContactWang Bin

Longgang Central Hospital of Shenzhen

yy_bwang@hotmail.com+86 84806933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026